chr1_-_68470585
|
1.937
|
NM_001002292
NM_001193334
NM_024911
|
WLS
|
wntless homolog (Drosophila)
|
chr19_+_60487578
|
1.831
|
|
BRSK1
|
BR serine/threonine kinase 1
|
chr19_-_36531958
|
1.777
|
NM_020856
|
TSHZ3
|
teashirt zinc finger homeobox 3
|
chr19_+_60487345
|
1.642
|
NM_032430
|
BRSK1
|
BR serine/threonine kinase 1
|
chr1_-_20685314
|
1.524
|
NM_018584
|
CAMK2N1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1
|
chr16_-_30929217
|
1.445
|
NM_052874
|
STX1B
|
syntaxin 1B
|
chr6_-_153494076
|
1.391
|
NM_012419
|
RGS17
|
regulator of G-protein signaling 17
|
chr7_+_128218685
|
1.366
|
|
CCDC136
|
coiled-coil domain containing 136
|
chr19_-_56178882
|
1.351
|
NM_139277
NM_005046
|
KLK7
|
kallikrein-related peptidase 7
|
chr5_-_81082699
|
1.280
|
NM_012446
|
SSBP2
|
single-stranded DNA binding protein 2
|
chr17_+_58058774
|
1.263
|
|
MRC2
|
mannose receptor, C type 2
|
chr6_-_10520264
|
1.240
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
chr6_-_29708647
|
1.223
|
|
GABBR1
|
gamma-aminobutyric acid (GABA) B receptor, 1
|
chr5_-_81082614
|
1.222
|
|
SSBP2
|
single-stranded DNA binding protein 2
|
chr4_-_177950658
|
1.221
|
NM_005429
|
VEGFC
|
vascular endothelial growth factor C
|
chr2_-_144994038
|
1.205
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
chr2_-_144994349
|
1.160
|
NM_001171653
NM_014795
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
chr6_-_10520592
|
1.127
|
NM_001032280
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
chr7_+_103756339
|
1.098
|
NM_199000
|
LHFPL3
|
lipoma HMGIC fusion partner-like 3
|
chr1_+_156229934
|
1.076
|
|
KIRREL
|
kin of IRRE like (Drosophila)
|
chr13_+_113574925
|
1.059
|
NM_001143945
|
GAS6
|
growth arrest-specific 6
|
chr17_+_58058479
|
1.029
|
NM_006039
|
MRC2
|
mannose receptor, C type 2
|
chr17_-_55824083
|
1.025
|
|
USP32
|
ubiquitin specific peptidase 32
|
chr6_-_42527760
|
1.018
|
NM_033502
|
TRERF1
|
transcriptional regulating factor 1
|
chr9_+_108665168
|
0.999
|
NM_021224
|
ZNF462
|
zinc finger protein 462
|
chr6_-_29708838
|
0.974
|
|
GABBR1
|
gamma-aminobutyric acid (GABA) B receptor, 1
|
chr15_-_80125514
|
0.974
|
|
MEX3B
|
mex-3 homolog B (C. elegans)
|
chr21_-_27139563
|
0.968
|
NM_006988
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1
|
chr19_-_1966628
|
0.965
|
NM_017797
|
BTBD2
|
BTB (POZ) domain containing 2
|
chr8_-_116750427
|
0.950
|
|
TRPS1
|
trichorhinophalangeal syndrome I
|
chr12_+_52618815
|
0.946
|
NM_017410
|
HOXC13
|
homeobox C13
|
chr16_-_63713382
|
0.926
|
NM_001797
|
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast)
|
chr5_-_36912487
|
0.908
|
|
LOC646719
|
hypothetical LOC646719
|
chr21_-_27139143
|
0.900
|
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1
|
chr11_+_129689536
|
0.881
|
|
FLJ34521
|
hypothetical protein LOC646383
|
chr22_-_44751671
|
0.880
|
NM_058238
|
WNT7B
|
wingless-type MMTV integration site family, member 7B
|
chr17_+_58058783
|
0.877
|
|
MRC2
|
mannose receptor, C type 2
|
chrX_+_73557809
|
0.874
|
NM_006517
|
SLC16A2
|
solute carrier family 16, member 2 (monocarboxylic acid transporter 8)
|
chr2_+_45022540
|
0.855
|
NM_005413
|
SIX3
|
SIX homeobox 3
|
chr8_+_22078622
|
0.850
|
|
BMP1
|
bone morphogenetic protein 1
|
chr15_+_90197884
|
0.840
|
NM_001145044
NM_013272
|
SLCO3A1
|
solute carrier organic anion transporter family, member 3A1
|
chr4_-_158111995
|
0.833
|
NM_016205
|
PDGFC
|
platelet derived growth factor C
|
chrX_+_56275510
|
0.828
|
NM_007250
NM_001159296
|
KLF8
|
Kruppel-like factor 8
|
chr11_+_93916653
|
0.823
|
NM_002033
|
PIWIL4
FUT4
|
piwi-like 4 (Drosophila)
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
chr5_+_176492662
|
0.796
|
NM_172349
|
NSD1
|
nuclear receptor binding SET domain protein 1
|
chr19_-_48976852
|
0.790
|
|
KCNN4
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4
|
chr1_-_68071635
|
0.787
|
NM_018841
|
GNG12
|
guanine nucleotide binding protein (G protein), gamma 12
|
chr11_+_12355600
|
0.777
|
NM_018222
|
PARVA
|
parvin, alpha
|
chrX_+_144707022
|
0.774
|
NM_001144003
NM_001144004
NM_001144005
NM_032539
|
SLITRK2
|
SLIT and NTRK-like family, member 2
|
chr11_+_124539814
|
0.774
|
|
PKNOX2
|
PBX/knotted 1 homeobox 2
|
chr3_+_152287365
|
0.772
|
NM_053002
|
MED12L
|
mediator complex subunit 12-like
|
chr11_-_78829342
|
0.766
|
NM_001098816
|
ODZ4
|
odz, odd Oz/ten-m homolog 4 (Drosophila)
|
chr11_-_66897584
|
0.762
|
NM_013246
|
CLCF1
|
cardiotrophin-like cytokine factor 1
|
chr5_+_176493233
|
0.760
|
NM_022455
|
NSD1
|
nuclear receptor binding SET domain protein 1
|
chr16_-_63713485
|
0.753
|
|
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast)
|
chr6_+_96570565
|
0.751
|
NM_006581
|
FUT9
|
fucosyltransferase 9 (alpha (1,3) fucosyltransferase)
|
chr3_-_64648703
|
0.750
|
|
ADAMTS9
|
ADAM metallopeptidase with thrombospondin type 1 motif, 9
|
chr1_+_199884152
|
0.748
|
|
NAV1
|
neuron navigator 1
|
chr15_+_41597097
|
0.746
|
NM_002373
|
MAP1A
|
microtubule-associated protein 1A
|
chr3_-_162572441
|
0.736
|
NM_001040100
|
C3orf57
|
chromosome 3 open reading frame 57
|
chr8_-_116750277
|
0.733
|
NM_014112
|
TRPS1
|
trichorhinophalangeal syndrome I
|
chr1_+_199884072
|
0.729
|
NM_020443
|
NAV1
|
neuron navigator 1
|
chr12_+_54612055
|
0.728
|
NM_201444
NM_201445
NM_201554
|
DGKA
|
diacylglycerol kinase, alpha 80kDa
|
chr16_+_12902955
|
0.728
|
NM_001145204
NM_001145205
|
SHISA9
|
shisa homolog 9 (Xenopus laevis)
|
chr1_+_26609893
|
0.717
|
|
LIN28A
|
lin-28 homolog A (C. elegans)
|
chr1_+_156229686
|
0.717
|
NM_018240
|
KIRREL
|
kin of IRRE like (Drosophila)
|
chr5_+_176493488
|
0.716
|
|
NSD1
|
nuclear receptor binding SET domain protein 1
|
chr6_-_33268177
|
0.712
|
NM_001163771
NM_080679
NM_080680
NM_080681
|
COL11A2
|
collagen, type XI, alpha 2
|
chr17_-_44058612
|
0.707
|
NM_024017
|
HOXB9
|
homeobox B9
|
chr16_-_63713466
|
0.702
|
|
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast)
|
chr17_+_45488356
|
0.699
|
|
ITGA3
|
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
|
chr6_-_29708938
|
0.697
|
NM_001470
NM_021904
|
GABBR1
|
gamma-aminobutyric acid (GABA) B receptor, 1
|
chr4_-_101090431
|
0.694
|
|
H2AFZ
|
H2A histone family, member Z
|
chr3_-_187025438
|
0.690
|
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2
|
chr12_+_4253143
|
0.689
|
NM_001759
|
CCND2
|
cyclin D2
|
chr1_+_165865953
|
0.687
|
NM_052862
|
RCSD1
|
RCSD domain containing 1
|
chr7_+_121300394
|
0.680
|
NM_002851
|
PTPRZ1
|
protein tyrosine phosphatase, receptor-type, Z polypeptide 1
|
chr15_-_56829069
|
0.674
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
chr8_+_22078817
|
0.661
|
|
BMP1
|
bone morphogenetic protein 1
|
chr1_-_194844299
|
0.656
|
|
KCNT2
|
potassium channel, subfamily T, member 2
|
chr10_-_61139328
|
0.656
|
NM_194298
|
LOC100129721
SLC16A9
|
hypothetical protein LOC100129721
solute carrier family 16, member 9 (monocarboxylic acid transporter 9)
|
chr8_-_9045548
|
0.653
|
NM_024607
|
PPP1R3B
|
protein phosphatase 1, regulatory (inhibitor) subunit 3B
|
chr12_+_56284867
|
0.651
|
NM_178502
|
DTX3
|
deltex homolog 3 (Drosophila)
|
chr8_+_104582151
|
0.650
|
NM_001100117
|
RIMS2
|
regulating synaptic membrane exocytosis 2
|
chrX_+_117513899
|
0.641
|
NM_144658
|
DOCK11
|
dedicator of cytokinesis 11
|
chr2_-_192767494
|
0.635
|
|
TMEFF2
|
transmembrane protein with EGF-like and two follistatin-like domains 2
|
chr2_+_113709553
|
0.634
|
|
LOC654433
|
hypothetical LOC654433
|
chr7_+_115952279
|
0.633
|
NM_001172895
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
chr1_+_221955876
|
0.628
|
NM_001146068
|
CAPN2
|
calpain 2, (m/II) large subunit
|
chr5_+_176493752
|
0.623
|
|
NSD1
|
nuclear receptor binding SET domain protein 1
|
chr6_-_46246543
|
0.621
|
NM_021572
|
ENPP5
|
ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative)
|
chr8_-_105670300
|
0.618
|
|
LRP12
|
low density lipoprotein receptor-related protein 12
|
chr4_-_140696740
|
0.617
|
NM_030648
|
SETD7
|
SET domain containing (lysine methyltransferase) 7
|
chr8_-_105670410
|
0.610
|
NM_001135703
NM_013437
|
LRP12
|
low density lipoprotein receptor-related protein 12
|
chr2_-_144991556
|
0.610
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
chr8_-_11096257
|
0.610
|
NM_173683
|
XKR6
|
XK, Kell blood group complex subunit-related family, member 6
|
chr19_-_60573552
|
0.599
|
NM_000641
|
IL11
|
interleukin 11
|
chr2_-_166358792
|
0.595
|
|
GALNT3
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3)
|
chr12_+_81604752
|
0.593
|
|
TMTC2
|
transmembrane and tetratricopeptide repeat containing 2
|
chr11_-_122571046
|
0.590
|
|
CLMP
|
CXADR-like membrane protein
|
chr11_-_122571198
|
0.586
|
NM_024769
|
CLMP
|
CXADR-like membrane protein
|
chr4_+_145786622
|
0.583
|
NM_022475
|
HHIP
|
hedgehog interacting protein
|
chr15_+_90738108
|
0.582
|
NM_006011
|
ST8SIA2
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2
|
chr6_+_69401660
|
0.582
|
NM_001704
|
BAI3
|
brain-specific angiogenesis inhibitor 3
|
chr4_-_101090505
|
0.580
|
NM_002106
|
H2AFZ
|
H2A histone family, member Z
|
chr17_-_39265965
|
0.579
|
NM_001932
|
MPP3
|
membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3)
|
chr3_-_170864111
|
0.578
|
NM_004991
|
MECOM
|
MDS1 and EVI1 complex locus
|
chr3_-_187025501
|
0.574
|
NM_001007225
NM_006548
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2
|
chr8_-_22044463
|
0.572
|
NM_005144
NM_018411
|
HR
|
hairless homolog (mouse)
|
chr1_-_231498081
|
0.566
|
NM_014801
|
PCNXL2
|
pecanex-like 2 (Drosophila)
|
chr7_+_106472243
|
0.564
|
NM_002736
|
PRKAR2B
|
protein kinase, cAMP-dependent, regulatory, type II, beta
|
chr7_-_140270749
|
0.562
|
NM_004333
|
BRAF
|
v-raf murine sarcoma viral oncogene homolog B1
|
chr19_-_13478037
|
0.559
|
NM_000068
NM_001127221
NM_001127222
NM_001174080
NM_023035
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
chr19_+_60691671
|
0.559
|
NM_001144950
NM_001195267
|
SSC5D
|
scavenger receptor cysteine rich domain containing (5 domains)
|
chr6_-_75972473
|
0.557
|
|
COL12A1
|
collagen, type XII, alpha 1
|
chr9_+_8848130
|
0.548
|
|
|
|
chr12_-_6354818
|
0.548
|
|
SCNN1A
|
sodium channel, nonvoltage-gated 1 alpha
|
chr2_+_79593679
|
0.548
|
|
CTNNA2
|
catenin (cadherin-associated protein), alpha 2
|
chr4_-_158111504
|
0.546
|
|
PDGFC
|
platelet derived growth factor C
|
chr5_+_76542461
|
0.545
|
NM_001029851
NM_001029852
NM_001029853
NM_001029854
NM_003719
|
PDE8B
|
phosphodiesterase 8B
|
chr15_-_80125403
|
0.545
|
NM_032246
|
MEX3B
|
mex-3 homolog B (C. elegans)
|
chr7_+_68702252
|
0.544
|
|
AUTS2
|
autism susceptibility candidate 2
|
chr5_+_148766632
|
0.541
|
|
LOC728264
|
hypothetical LOC728264
|
chr2_-_19421852
|
0.538
|
NM_145260
|
OSR1
|
odd-skipped related 1 (Drosophila)
|
chr12_+_74071145
|
0.536
|
NM_152436
|
GLIPR1L2
|
GLI pathogenesis-related 1 like 2
|
chr4_+_30331289
|
0.535
|
|
PCDH7
|
protocadherin 7
|
chr20_-_47532585
|
0.531
|
NM_004975
|
KCNB1
|
potassium voltage-gated channel, Shab-related subfamily, member 1
|
chr4_-_122213018
|
0.530
|
NM_024574
|
C4orf31
|
chromosome 4 open reading frame 31
|
chr13_-_71339313
|
0.530
|
NM_004392
NM_080759
NM_080760
|
DACH1
|
dachshund homolog 1 (Drosophila)
|
chr9_+_115678365
|
0.527
|
NM_133374
|
ZNF618
|
zinc finger protein 618
|
chr6_+_21774624
|
0.527
|
|
FLJ22536
|
hypothetical locus LOC401237
|
chr11_-_106394039
|
0.525
|
NM_000855
|
GUCY1A2
|
guanylate cyclase 1, soluble, alpha 2
|
chr3_+_121296290
|
0.524
|
|
|
|
chr3_-_121652183
|
0.520
|
NM_007085
|
FSTL1
|
follistatin-like 1
|
chr19_-_54031725
|
0.510
|
NM_016246
|
HSD17B14
|
hydroxysteroid (17-beta) dehydrogenase 14
|
chr4_+_30330963
|
0.507
|
NM_001173523
NM_002589
NM_032456
NM_032457
|
PCDH7
|
protocadherin 7
|
chr1_-_29322993
|
0.507
|
NM_001003682
|
TMEM200B
|
transmembrane protein 200B
|
chr22_-_15982142
|
0.505
|
NM_031890
NM_001163079
|
CECR6
|
cat eye syndrome chromosome region, candidate 6
|
chrX_+_109132507
|
0.502
|
NM_017698
|
TMEM164
|
transmembrane protein 164
|
chr9_-_16860719
|
0.501
|
NM_017637
|
BNC2
|
basonuclin 2
|
chrX_+_109132994
|
0.497
|
NM_032227
|
TMEM164
|
transmembrane protein 164
|
chr18_-_70416018
|
0.495
|
|
LOC400657
|
hypothetical LOC400657
|
chr8_+_22078589
|
0.491
|
NM_001199
NM_006129
|
BMP1
|
bone morphogenetic protein 1
|
chr1_+_158636987
|
0.491
|
NM_020335
|
VANGL2
|
vang-like 2 (van gogh, Drosophila)
|
chr7_-_150283794
|
0.490
|
NM_172057
|
KCNH2
|
potassium voltage-gated channel, subfamily H (eag-related), member 2
|
chr12_+_92488932
|
0.490
|
|
SOCS2
|
suppressor of cytokine signaling 2
|
chr4_-_96689373
|
0.486
|
NM_003728
|
UNC5C
|
unc-5 homolog C (C. elegans)
|
chr16_+_54782751
|
0.483
|
NM_020988
NM_138736
|
GNAO1
|
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O
|
chrX_-_153016173
|
0.481
|
|
MECP2
LOC728653
|
methyl CpG binding protein 2 (Rett syndrome)
hypothetical protein LOC728653
|
chr12_-_48387394
|
0.476
|
|
FMNL3
|
formin-like 3
|
chr5_-_137117936
|
0.475
|
NM_006805
|
HNRNPA0
|
heterogeneous nuclear ribonucleoprotein A0
|
chr7_+_93861808
|
0.474
|
NM_000089
|
COL1A2
|
collagen, type I, alpha 2
|
chr21_+_38550533
|
0.473
|
NM_002243
|
KCNJ15
|
potassium inwardly-rectifying channel, subfamily J, member 15
|
chr10_-_79067296
|
0.469
|
|
KCNMA1
|
potassium large conductance calcium-activated channel, subfamily M, alpha member 1
|
chr7_+_90731671
|
0.465
|
NM_003505
|
FZD1
|
frizzled homolog 1 (Drosophila)
|
chr11_-_118167108
|
0.464
|
NM_004397
|
DDX6
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 6
|
chr17_-_43977273
|
0.462
|
NM_002145
|
HOXB2
|
homeobox B2
|
chr19_-_11452439
|
0.460
|
NM_001420
NM_032281
|
ELAVL3
|
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C)
|
chr10_+_23424383
|
0.460
|
NM_012228
|
MSRB2
|
methionine sulfoxide reductase B2
|
chr3_+_20056857
|
0.458
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
chr11_+_102485293
|
0.457
|
NM_001080463
NM_001377
|
DYNC2H1
|
dynein, cytoplasmic 2, heavy chain 1
|
chr4_+_174326464
|
0.455
|
NM_017423
|
GALNT7
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GalNAc-T7)
|
chr11_-_66898223
|
0.452
|
NM_001166212
|
CLCF1
|
cardiotrophin-like cytokine factor 1
|
chr20_-_47618059
|
0.448
|
NM_000961
|
PTGIS
|
prostaglandin I2 (prostacyclin) synthase
|
chr5_+_176492629
|
0.448
|
|
NSD1
|
nuclear receptor binding SET domain protein 1
|
chr5_-_178704934
|
0.448
|
|
ADAMTS2
|
ADAM metallopeptidase with thrombospondin type 1 motif, 2
|
chr12_+_56291484
|
0.446
|
NM_182947
|
ARHGEF25
|
Rho guanine nucleotide exchange factor (GEF) 25
|
chr17_+_2443652
|
0.444
|
NM_000430
|
PAFAH1B1
|
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa)
|
chr16_-_30841938
|
0.444
|
|
NCRNA00095
|
non-protein coding RNA 95
|
chr9_+_130491668
|
0.444
|
|
SET
|
SET nuclear oncogene
|
chr5_+_137829065
|
0.443
|
|
EGR1
|
early growth response 1
|
chr6_-_80713589
|
0.440
|
NM_022726
|
ELOVL4
|
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 4
|
chr5_-_137906814
|
0.439
|
NM_004730
|
ETF1
|
eukaryotic translation termination factor 1
|
chr12_-_6354650
|
0.438
|
NM_001159576
|
SCNN1A
|
sodium channel, nonvoltage-gated 1 alpha
|
chr13_-_35603513
|
0.436
|
NM_004734
|
DCLK1
|
doublecortin-like kinase 1
|
chr9_+_138341752
|
0.435
|
NM_001145638
NM_015597
|
GPSM1
|
G-protein signaling modulator 1
|
chr1_-_200946038
|
0.435
|
NM_177402
|
SYT2
|
synaptotagmin II
|
chr7_+_32734244
|
0.433
|
|
LOC441208
|
zinc and ring finger 2 pseudogene
|
chr5_+_31229549
|
0.431
|
NM_004932
|
CDH6
|
cadherin 6, type 2, K-cadherin (fetal kidney)
|
chr10_-_88116181
|
0.429
|
NM_017551
|
GRID1
|
glutamate receptor, ionotropic, delta 1
|
chr7_-_82629735
|
0.426
|
|
PCLO
|
piccolo (presynaptic cytomatrix protein)
|
chr5_-_64813459
|
0.426
|
NM_197941
|
ADAMTS6
|
ADAM metallopeptidase with thrombospondin type 1 motif, 6
|
chr18_+_53170718
|
0.425
|
NM_015879
|
ST8SIA3
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3
|
chr8_-_122722674
|
0.425
|
NM_005328
|
HAS2
|
hyaluronan synthase 2
|
chr2_-_200030412
|
0.424
|
|
SATB2
|
SATB homeobox 2
|
chrX_-_151370325
|
0.424
|
NM_000808
|
GABRA3
|
gamma-aminobutyric acid (GABA) A receptor, alpha 3
|
chr7_+_93862137
|
0.421
|
|
COL1A2
PLAG1
|
collagen, type I, alpha 2
pleiomorphic adenoma gene 1
|
chr15_-_69194854
|
0.420
|
NM_001102658
|
CT62
|
cancer/testis antigen 62
|
chr13_+_99431417
|
0.419
|
|
|
|
chr19_-_54958326
|
0.418
|
NM_021733
|
TSKS
|
testis-specific serine kinase substrate
|
chr12_+_47495567
|
0.416
|
|
CACNB3
|
calcium channel, voltage-dependent, beta 3 subunit
|
chr9_+_129414287
|
0.416
|
NM_001032221
NM_003165
|
STXBP1
|
syntaxin binding protein 1
|
chr12_-_33483847
|
0.415
|
NM_198992
|
SYT10
|
synaptotagmin X
|
chr12_-_51912101
|
0.415
|
NM_000966
|
RARG
|
retinoic acid receptor, gamma
|
chr15_+_99237527
|
0.415
|
NM_000693
|
ALDH1A3
|
aldehyde dehydrogenase 1 family, member A3
|
chr14_-_90596665
|
0.412
|
NM_004755
NM_182398
|
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5
|
chr11_-_3143051
|
0.411
|
|
OSBPL5
|
oxysterol binding protein-like 5
|
chr21_-_44583505
|
0.410
|
|
C21orf2
|
chromosome 21 open reading frame 2
|
chr1_+_55237193
|
0.409
|
NM_057176
|
BSND
|
Bartter syndrome, infantile, with sensorineural deafness (Barttin)
|
chr15_+_99237555
|
0.409
|
|
ALDH1A3
|
aldehyde dehydrogenase 1 family, member A3
|